Integrated CRO Quartesian is now part of Veranex, placing them within a broader platform that spans product design, medical device evaluation, clinical development, data management, regulatory, and market access. This offers a compelling upsell to clients seeking end-to-end solutions from concept to commercialization.

Clinical Data Expertise With over a decade of clinical data services focusing on statistical programming, data management, study design, and submissions, there is a clear opportunity to cross-sell broader Veranex capabilities to biopharma and medical device clients seeking end-to-end trial and submission support.

Strategic Partnerships Past collaborations with Amyndas Pharmaceuticals and a multi-year engagement with Medrio highlight a track record of partner-led growth. Target similar biotech and device firms looking for reliable data services and eClinical integration within a turnkey framework.

Scale and Reach Operating with 51-200 employees and revenue in the 10–25M range, Quartesian sits between smaller CROs and larger, full-service providers. This positioning is attractive to mid-market biopharma and mid-tier device companies seeking high-quality services with responsive delivery.

Tech Stack Fit A tech-forward profile including Veeva Systems, React, and other modern tools indicates compatibility with clients already using leading eClinical and CRM platforms. This enables streamlined integration, faster project onboarding, and measurable data-driven outcomes for sales conversations.